RecruitingNot ApplicableNCT06421324

Personalised Health Recommendations to the General Population Through an Integrated AI Guided

Interventional Study Focused on Providing Personalised Health Recommendations to the General Population Through an Integrated AI Guided App as a Strategy for Gastric Cancer Prevention (AIDA)


Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia

Enrollment

450 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical study aims to be used to implement and validate the AIDA tool in two phases: * Phase 1: Risk stratification and personalised recommendations \& Model development * Phase 2: Mechanistic Model (Bioresource) development \& testing


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a personalized AI-guided health platform can improve outcomes for patients who have had H. pylori infection or gastric intestinal metaplasia (GIM) — precancerous changes in the stomach lining. The AI provides tailored diet, lifestyle, and health recommendations. **You may be eligible if...** - You are 18 or older with a diagnosis of gastric intestinal metaplasia (GIM) or a history of H. pylori infection - You are scheduled for a gastroscopy (stomach camera) as part of your usual care - You can provide written consent **You may NOT be eligible if...** - You are having the endoscopy for a different reason (e.g., treating varices, placing a feeding tube) - You have been diagnosed with another stomach condition not related to GIM or gastric cancer - You received antibiotics in the past 4 weeks, or proton pump inhibitors (like omeprazole) in the past 2 weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHealth reccommendations

Patients are given recommendations according to their risk group, based on the model which already predicted health indicators. This information will be sent to the patient's treating physician so that treatment and recommendations are aligned with the clinical care practice based on the European Code of Cancer guidelines, the H. pylori best practices guidelines and European GIM guidelines


Locations(1)

Hospital Clínico Universitario de Valencia

Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06421324


Related Trials